Shek, D.; Akhuba, L.; Carlino, M.S.; Nagrial, A.; Moujaber, T.; Read, S.A.; Gao, B.; Ahlenstiel, G.
Immune-Checkpoint Inhibitors for Metastatic Colorectal Cancer: A Systematic Review of Clinical Outcomes. Cancers 2021, 13, 4345.
https://doi.org/10.3390/cancers13174345
AMA Style
Shek D, Akhuba L, Carlino MS, Nagrial A, Moujaber T, Read SA, Gao B, Ahlenstiel G.
Immune-Checkpoint Inhibitors for Metastatic Colorectal Cancer: A Systematic Review of Clinical Outcomes. Cancers. 2021; 13(17):4345.
https://doi.org/10.3390/cancers13174345
Chicago/Turabian Style
Shek, Dmitrii, Liia Akhuba, Matteo S. Carlino, Adnan Nagrial, Tania Moujaber, Scott A. Read, Bo Gao, and Golo Ahlenstiel.
2021. "Immune-Checkpoint Inhibitors for Metastatic Colorectal Cancer: A Systematic Review of Clinical Outcomes" Cancers 13, no. 17: 4345.
https://doi.org/10.3390/cancers13174345
APA Style
Shek, D., Akhuba, L., Carlino, M. S., Nagrial, A., Moujaber, T., Read, S. A., Gao, B., & Ahlenstiel, G.
(2021). Immune-Checkpoint Inhibitors for Metastatic Colorectal Cancer: A Systematic Review of Clinical Outcomes. Cancers, 13(17), 4345.
https://doi.org/10.3390/cancers13174345